Lantern Pharma Inc. Current Assets
Lantern Pharma Inc. (LTRN) had Current Assets of $8.46 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-14
- 2026-06-30: Assets, Current $8.46M.
- 2026-03-31: Assets, Current $7.06M.
- 2025-12-31: Assets, Current $10.80M.
- 2025-09-30: Assets, Current $13.46M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $8.46M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $7.06M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $10.80M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $13.46M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $17.20M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $20.82M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $25.25M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $29.92M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $35.29M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $39.47M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $43.34M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $47.43M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $51.04M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $55.17M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $58.72M 10-K · filed 2024-03-18 | |
| 2022-09-30 | $62.02M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $65.66M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $67.66M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $72.72M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $76.34M 10-Q · filed 2021-11-01 | |
| 2021-06-30 | $82.13M 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $82.48M 10-Q · filed 2021-05-03 | |
| 2020-12-31 | $20.24M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $22.48M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $25.60M 10-Q · filed 2020-07-30 | |
| 2019-12-31 | $1.23M 10-K · filed 2021-03-10 | $1.23M 10-Q · filed 2020-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |